Green synthesis of silver nanoparticles via plant extracts: beginning a new era in cancer theranostics

Author:

Ovais Muhammad1,Khalil Ali Talha1,Raza Abida2,Khan Muhammad Adeeb3,Ahmad Irshad4,Islam Nazar Ul5,Saravanan Muthupandian6,Ubaid Muhammad Furqan7,Ali Muhammad1,Shinwari Zabta Khan18

Affiliation:

1. Department of Biotechnology, Quaid-i-Azam University, Islamabad, Pakistan

2. National Institute for Lasers & Optronics, Pakistan Atomic Energy Commission, Islamabad, Pakistan

3. Department of Zoology, University of Azad Jammu & Kashmir, Muzaffarabad, Pakistan

4. Department of Life sciences, King Fahd University of Petroleum & Minerals, Dhahran, Saudi Arabia

5. Department of Pharmacy, Sarhad University of Science & Information Technology, Peshawar, Pakistan

6. Department of Medical Microbiology & Immunology, Institute of Biomedical Sciences, College of Health Sciences, Mekelle University, Mekelle, Ethiopia

7. Azad Jammu & Kashmir Medical College, Muzaffarabad, Pakistan

8. Pakistan Academy of Sciences, Islamabad, Pakistan

Abstract

With the development of the latest technologies, scientists are looking to design novel strategies for the treatment and diagnosis of cancer. Advances in medicinal plant research and nanotechnology have attracted many researchers to the green synthesis of metallic nanoparticles due to its several advantages over conventional synthesis (simple, fast, energy efficient, one pot processes, safer, economical and biocompatibility). Medicinally active plants have proven to be the best reservoirs of diverse phytochemicals for the synthesis of biogenic silver nanoparticles (AgNPs). In this review, we discuss mechanistic advances in the synthesis and optimization of AgNPs from plant extracts. Moreover, we have thoroughly discussed the recent developments and milestones achieved in the use of biogenic AgNPs as cancer theranostic agents and their proposed mechanism of action. Anticipating all of the challenges, we hope that biogenic AgNPs may become a potential cancer theranostic agent in the near future.

Publisher

Future Medicine Ltd

Subject

Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Reference150 articles.

1. Informatics IIFH. Use of Opioid Recovery Medications. www.imshealth.com/en/thought-leadership/ims-institute.

2. The global burden of cancer

3. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Cited by 253 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3